PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31560593-1 2019 Objective(s): The incorporation of Arginine (Arg) in NaF-containing child dentifrice might enhance its remineralizing potential, reducing fluorosis risk with significant anti-caries benefit. Arginine 35-43 C-X-C motif chemokine ligand 8 Homo sapiens 53-56 32064872-4 2020 In porcine intestinal epithelial cells (IPEC-J2), L-arginine obviously suppressed (p < 0.05) the levels of IL-6 (220.63 +- 2.82), IL-8 (333.95 +- 3.75), IL-1beta (693.08 +- 2.38) and TNF-alpha (258.04 +- 4.14) induced by LPS. Arginine 50-60 C-X-C motif chemokine ligand 8 Homo sapiens 133-137 31560593-1 2019 Objective(s): The incorporation of Arginine (Arg) in NaF-containing child dentifrice might enhance its remineralizing potential, reducing fluorosis risk with significant anti-caries benefit. Arginine 35-38 C-X-C motif chemokine ligand 8 Homo sapiens 53-56 31560593-5 2019 Results: The percentage remineralization of the 2% Arg-NaF and 1100-ppm NaF groups was significantly higher than the 600-ppm NaF group (p<0.001). Arginine 51-54 C-X-C motif chemokine ligand 8 Homo sapiens 55-58 31560593-7 2019 The EFU, Ca/P ratio, PO43- content of the 2% Arg-NaF group were significantly higher than the 600-ppm NaF group (p<0.01); while no significant difference was found between the 2% Arg-NaF and 1100-ppm NaF groups. Arginine 45-48 C-X-C motif chemokine ligand 8 Homo sapiens 49-52 31560593-8 2019 Conclusion: Within the limitations of the present study, incorporation of 2% arginine in 600-ppm NaF child formula dentifrice enhanced the remineralization potential of artificial enamel caries, to a level comparable to 1100-ppm NaF adult formula dentifrice. Arginine 77-85 C-X-C motif chemokine ligand 8 Homo sapiens 97-100 22891766-5 2012 In this novel mechanism, TWIST1-mediated IL8 transcription is induced through the TWIST1 carboxy-terminal WR (Trp-Arg) domain instead of the classic DNA binding bHLH domain. Arginine 114-117 C-X-C motif chemokine ligand 8 Homo sapiens 41-44 26826259-7 2017 Glutamine, arginine, and vitamin D3, but not ALA, significantly attenuated IL-8 production. Arginine 11-19 C-X-C motif chemokine ligand 8 Homo sapiens 75-79 26826259-9 2017 Combining glutamine, arginine, and curcumin at optimal concentrations completely abolished the IL-8 response. Arginine 21-29 C-X-C motif chemokine ligand 8 Homo sapiens 95-99 19022976-7 2008 Arg(high)/Gln(high) decreased the production of TNFalpha, IL-1beta, IL-8, and IL-6 (each P < 0.01). Arginine 0-3 C-X-C motif chemokine ligand 8 Homo sapiens 68-72 19489187-5 2009 The study also showed that this new arginine toothpaste provided significantly greater reductions (p < 0.05) in dentin hypersensitivity in response to tactile (16.2%, 22.4%, and 21.4%) and air blast (16.2%, 29.2%, and 63.4%) stimuli than the benchmark commercial toothpaste containing 2% potassium ion and 1450 ppm NaF in a silica base, after two, four, and eight weeks of product use, respectively. Arginine 36-44 C-X-C motif chemokine ligand 8 Homo sapiens 318-321 19489188-5 2009 The study also showed that this new arginine toothpaste provided significantly greater reductions (p < 0.05) in dentin hypersensitivity in response to tactile (37.0%, 30.0%, and 12.2%) and air blast (23.9%, 32.0%, and 29.3%) stimuli than the commercial sensitive toothpaste containing 2% potassium ion and 1450 ppm fluoride as NaF in a silica base, after two weeks, four weeks, and eight weeks of product use, respectively. Arginine 36-44 C-X-C motif chemokine ligand 8 Homo sapiens 330-333 22194966-2 2011 This posttranslational modification of arginine was recently discovered on inflammatory chemokines including CXCL8 and CXCL10, and significantly reduced their biological activity. Arginine 39-47 C-X-C motif chemokine ligand 8 Homo sapiens 109-114 19575800-2 2009 Availability of the non-essential amino acid arginine in the inflamed airway mucosa of patients with asthma is reduced markedly, but it is not known whether this can also lead to an exaggerated production of IL-6 and IL-8. Arginine 45-53 C-X-C motif chemokine ligand 8 Homo sapiens 217-221 19575800-7 2009 RESULTS: For both NCI-H292 and NHBE cells, low arginine concentrations enhanced basal epithelial IL-6 and IL-8 production and synergized with TNF-alpha-induced IL-6 and IL-8 production. Arginine 47-55 C-X-C motif chemokine ligand 8 Homo sapiens 106-110 19575800-7 2009 RESULTS: For both NCI-H292 and NHBE cells, low arginine concentrations enhanced basal epithelial IL-6 and IL-8 production and synergized with TNF-alpha-induced IL-6 and IL-8 production. Arginine 47-55 C-X-C motif chemokine ligand 8 Homo sapiens 169-173 19575800-8 2009 Poly-L-arginine enhanced the stimulus-induced IL-6 and IL-8 production, however, blocking arginine uptake and the enhanced IL-6 and IL-8 production appeared unrelated. Arginine 7-15 C-X-C motif chemokine ligand 8 Homo sapiens 55-59 18712273-4 2009 Dietary supplementation with 0.8% arginine increased the numbers of white blood cells and granulocytes, and gene expression of interleukin (IL)-8 in spleen. Arginine 34-42 C-X-C motif chemokine ligand 8 Homo sapiens 127-145 18712273-5 2009 On Day 14, compared with control piglets, granulocyte numbers were greater but lymphocyte numbers were lower in piglets supplemented with 0.2 and 0.4% arginine, whereas splenic expression of IL-8 and tumor necrosis factor-alpha genes was increased in piglets supplemented with 0.8% arginine. Arginine 151-159 C-X-C motif chemokine ligand 8 Homo sapiens 191-227 18712273-5 2009 On Day 14, compared with control piglets, granulocyte numbers were greater but lymphocyte numbers were lower in piglets supplemented with 0.2 and 0.4% arginine, whereas splenic expression of IL-8 and tumor necrosis factor-alpha genes was increased in piglets supplemented with 0.8% arginine. Arginine 282-290 C-X-C motif chemokine ligand 8 Homo sapiens 191-227 19022976-8 2008 Arg(low)/Gln(high) decreased IL-6 and IL-8 production (both P < 0.01), whereas Arg(high)/Gln(low) did not affect cytokine and NO production. Arginine 0-3 C-X-C motif chemokine ligand 8 Homo sapiens 38-42 18066713-3 2008 When coincubating A549 with LPS and meta-iodobenzylguanidine or novobiocin, selective arginine-dependent ART-inhibitors, the release of IL-6 and IL-8 was inhibited in a concentration-dependent manner. Arginine 86-94 C-X-C motif chemokine ligand 8 Homo sapiens 145-149 18349372-3 2008 In contrast, arginine-specific gingipain 2 (RgpB) increased IL-8 production. Arginine 13-21 C-X-C motif chemokine ligand 8 Homo sapiens 60-64 17483743-5 2007 Among the PDF groups, IL-8 secretions from ECs and PMNs were lower with 100 and 1000 micromol/L Arg than with 0 and 50 micromol/L Arg, and this was consistent with the expression of the IL-8 receptor on PMNs. Arginine 96-99 C-X-C motif chemokine ligand 8 Homo sapiens 22-26 17483743-5 2007 Among the PDF groups, IL-8 secretions from ECs and PMNs were lower with 100 and 1000 micromol/L Arg than with 0 and 50 micromol/L Arg, and this was consistent with the expression of the IL-8 receptor on PMNs. Arginine 130-133 C-X-C motif chemokine ligand 8 Homo sapiens 22-26 17483743-5 2007 Among the PDF groups, IL-8 secretions from ECs and PMNs were lower with 100 and 1000 micromol/L Arg than with 0 and 50 micromol/L Arg, and this was consistent with the expression of the IL-8 receptor on PMNs. Arginine 130-133 C-X-C motif chemokine ligand 8 Homo sapiens 186-190 17483743-11 2007 Arginine administration at levels similar to or higher than physiological concentrations reduced IL-8 and CAM expression, and PMN transmigration was also decreased after stimulation with plasma or PDF from surgical patients. Arginine 0-8 C-X-C motif chemokine ligand 8 Homo sapiens 97-101 17375198-9 2007 MMP-8 cleaves CXCL8 at Arg(5)-Ser(6) and at Val(7)-Leu(8) in CXCL5 to activate respective chemokines. Arginine 23-26 C-X-C motif chemokine ligand 8 Homo sapiens 14-19 9485196-2 1998 It shares CXCR2 with all neutrophil-activating chemokines, which like IL-8 have a conserved Glu-Leu-Arg (ELR) N-terminal motif, but is generally considered to be the only relevant agonist for CXCR1. Arginine 100-103 C-X-C motif chemokine ligand 8 Homo sapiens 70-74 16040184-6 2005 Under stimulated conditions, arginine decreased IL-8 and Mig mRNA level (57% and 39%, for 0.1 vs. 2 mmol/l l-arginine, P<0.05, respectively), and production (respectively, 28 and 23%, both P<0.05). Arginine 29-37 C-X-C motif chemokine ligand 8 Homo sapiens 48-52 16040184-9 2005 Use of NG-Methyl-l-arginine acetate, a NOS inhibitor which prevents arginine-induced NO production, suppressed the arginine-induced IL-8 inhibition (P<0.05). Arginine 19-27 C-X-C motif chemokine ligand 8 Homo sapiens 132-136 16040184-9 2005 Use of NG-Methyl-l-arginine acetate, a NOS inhibitor which prevents arginine-induced NO production, suppressed the arginine-induced IL-8 inhibition (P<0.05). Arginine 68-76 C-X-C motif chemokine ligand 8 Homo sapiens 132-136 16040184-10 2005 In HCT-8 cells, arginine enhanced cytokine-induced NO production, reduced IL-8 and Mig production and mRNA level and had no effects on other assessed chemokines. Arginine 16-24 C-X-C motif chemokine ligand 8 Homo sapiens 74-78 16040184-11 2005 In conclusion, arginine-induced IL-8 inhibition in HCT-8 cells involves NO pathway under inflammatory conditions. Arginine 15-23 C-X-C motif chemokine ligand 8 Homo sapiens 32-36 12427973-4 2002 The proangiogenic N-terminal fragment mini-TyrRS has IL-8-like cytokine activity that, like other CXC cytokines, depends on a Glu-Leu-Arg motif. Arginine 134-137 C-X-C motif chemokine ligand 8 Homo sapiens 53-57 10707023-1 2000 The "ELR" (Glu-Leu-Arg) tripeptide sequence near the N-terminus of interleukin-8 (IL-8) contributes a large part of the receptor binding free energy. Arginine 19-22 C-X-C motif chemokine ligand 8 Homo sapiens 67-80 10707023-1 2000 The "ELR" (Glu-Leu-Arg) tripeptide sequence near the N-terminus of interleukin-8 (IL-8) contributes a large part of the receptor binding free energy. Arginine 19-22 C-X-C motif chemokine ligand 8 Homo sapiens 82-86 15755869-4 2005 Thrombin and SFLLRN (Ser-Phe-Leu-Leu-Arg-Asp), a PAR1 agonist peptide, increased the mRNA expression of IL-8, monocyte chemoattractant protein-1 (MCP-1), and cyclooxygenase-2 (COX-2) and the protein secretion of IL-8 nd MCP-1 in ESCs. Arginine 37-40 C-X-C motif chemokine ligand 8 Homo sapiens 104-108 12818188-7 2003 Moreover, human hepatic cathepsin L cleaved 77IL-8 between Arg(5) and Ser(6), which is the same cleavage site as the putative converting enzyme, resulting in 72IL-8 formation. Arginine 59-62 C-X-C motif chemokine ligand 8 Homo sapiens 46-50 9366309-6 1997 RESULTS: After 2 weeks to 1 month of oral L-arginine treatment, urinary levels of nitric oxide synthase related enzymes and products increased significantly, while levels of the cytokine IL-8 were not changed significantly. Arginine 42-52 C-X-C motif chemokine ligand 8 Homo sapiens 187-191 8200045-6 1994 These findings suggest that NMA, an inhibitor of the L-arginine metabolic pathway, may regulate the production of specific C-X-C chemokines, IL-8 and ENA-78, during a MLR. Arginine 53-63 C-X-C motif chemokine ligand 8 Homo sapiens 141-145 8034699-6 1994 Our study shows that, besides the extracellular domain cysteines which may be critical for the overall folding of the receptor, three residues, Arg-199, Arg-203, and Asp-265, are important for IL-8 binding and IL-8-mediated signal transduction. Arginine 144-147 C-X-C motif chemokine ligand 8 Homo sapiens 193-197 8034699-6 1994 Our study shows that, besides the extracellular domain cysteines which may be critical for the overall folding of the receptor, three residues, Arg-199, Arg-203, and Asp-265, are important for IL-8 binding and IL-8-mediated signal transduction. Arginine 144-147 C-X-C motif chemokine ligand 8 Homo sapiens 210-214 8034699-6 1994 Our study shows that, besides the extracellular domain cysteines which may be critical for the overall folding of the receptor, three residues, Arg-199, Arg-203, and Asp-265, are important for IL-8 binding and IL-8-mediated signal transduction. Arginine 153-156 C-X-C motif chemokine ligand 8 Homo sapiens 193-197 8420495-11 1993 CONCLUSION: Based on these results, we speculate that, although IL-8 may exert a synergistic effect with C5a/C5a des Arg in the induction of transepidermal leukocyte chemotaxis, it constitutes a proinflammatory cytokine that is involved in the production of the persistent inflammatory changes characterized by a T-lymphocyte infiltration. Arginine 117-120 C-X-C motif chemokine ligand 8 Homo sapiens 64-68 7524285-0 1993 L-arginine/nitric oxide pathway: a possible signal transduction mechanism for the regulation of the chemokine IL-8 in human mesangial cells. Arginine 0-10 C-X-C motif chemokine ligand 8 Homo sapiens 110-114 8103045-2 1993 We have previously demonstrated that a basic amino acid residue of interleukin (IL)-8, namely Arg-6, is critical for the binding of IL-8 to its receptor. Arginine 94-97 C-X-C motif chemokine ligand 8 Homo sapiens 67-85 8103045-2 1993 We have previously demonstrated that a basic amino acid residue of interleukin (IL)-8, namely Arg-6, is critical for the binding of IL-8 to its receptor. Arginine 94-97 C-X-C motif chemokine ligand 8 Homo sapiens 132-136 33421881-8 2021 Arginine and vitamin B6 supplemented into cell culture effectively decreased the levels of IL-6 and IL-8. Arginine 0-8 C-X-C motif chemokine ligand 8 Homo sapiens 100-104 1828038-1 1991 Plasmin mainly cleaved the Arg5-Ser6 bond of Arg-Val-Leu-Pro-Arg-interleukin-8 (AVLPR-IL-8) produced by human dermal fibroblasts, which resulted in the conversion of AVLPR-IL-8 to IL-8 and the inactive pentapeptide, though a minor cleavage of AVLPR-IL-8 by plasmin at Lys8-Glu9 bond occurred. Arginine 27-30 C-X-C motif chemokine ligand 8 Homo sapiens 65-78 1828038-1 1991 Plasmin mainly cleaved the Arg5-Ser6 bond of Arg-Val-Leu-Pro-Arg-interleukin-8 (AVLPR-IL-8) produced by human dermal fibroblasts, which resulted in the conversion of AVLPR-IL-8 to IL-8 and the inactive pentapeptide, though a minor cleavage of AVLPR-IL-8 by plasmin at Lys8-Glu9 bond occurred. Arginine 27-30 C-X-C motif chemokine ligand 8 Homo sapiens 86-90 1828038-1 1991 Plasmin mainly cleaved the Arg5-Ser6 bond of Arg-Val-Leu-Pro-Arg-interleukin-8 (AVLPR-IL-8) produced by human dermal fibroblasts, which resulted in the conversion of AVLPR-IL-8 to IL-8 and the inactive pentapeptide, though a minor cleavage of AVLPR-IL-8 by plasmin at Lys8-Glu9 bond occurred. Arginine 45-48 C-X-C motif chemokine ligand 8 Homo sapiens 65-78 1828038-1 1991 Plasmin mainly cleaved the Arg5-Ser6 bond of Arg-Val-Leu-Pro-Arg-interleukin-8 (AVLPR-IL-8) produced by human dermal fibroblasts, which resulted in the conversion of AVLPR-IL-8 to IL-8 and the inactive pentapeptide, though a minor cleavage of AVLPR-IL-8 by plasmin at Lys8-Glu9 bond occurred. Arginine 45-48 C-X-C motif chemokine ligand 8 Homo sapiens 86-90 1828038-1 1991 Plasmin mainly cleaved the Arg5-Ser6 bond of Arg-Val-Leu-Pro-Arg-interleukin-8 (AVLPR-IL-8) produced by human dermal fibroblasts, which resulted in the conversion of AVLPR-IL-8 to IL-8 and the inactive pentapeptide, though a minor cleavage of AVLPR-IL-8 by plasmin at Lys8-Glu9 bond occurred. Arginine 45-48 C-X-C motif chemokine ligand 8 Homo sapiens 172-176 1828038-1 1991 Plasmin mainly cleaved the Arg5-Ser6 bond of Arg-Val-Leu-Pro-Arg-interleukin-8 (AVLPR-IL-8) produced by human dermal fibroblasts, which resulted in the conversion of AVLPR-IL-8 to IL-8 and the inactive pentapeptide, though a minor cleavage of AVLPR-IL-8 by plasmin at Lys8-Glu9 bond occurred. Arginine 45-48 C-X-C motif chemokine ligand 8 Homo sapiens 172-176 1828038-1 1991 Plasmin mainly cleaved the Arg5-Ser6 bond of Arg-Val-Leu-Pro-Arg-interleukin-8 (AVLPR-IL-8) produced by human dermal fibroblasts, which resulted in the conversion of AVLPR-IL-8 to IL-8 and the inactive pentapeptide, though a minor cleavage of AVLPR-IL-8 by plasmin at Lys8-Glu9 bond occurred. Arginine 45-48 C-X-C motif chemokine ligand 8 Homo sapiens 172-176 33188848-15 2021 The Arg-NaF varnish appears a promising caries-preventive regimen that counters the pathogenic biofilms by Arg and promotes remineralization with fluorides. Arginine 4-7 C-X-C motif chemokine ligand 8 Homo sapiens 8-11 33711406-1 2021 OBJECTIVE: To examine the biochemical components of multi-species biofilm on the arginine (Arg)-sodium fluoride (NaF) varnish-treated enamel following bacterial pH-cycling. Arginine 81-89 C-X-C motif chemokine ligand 8 Homo sapiens 113-116 33711406-1 2021 OBJECTIVE: To examine the biochemical components of multi-species biofilm on the arginine (Arg)-sodium fluoride (NaF) varnish-treated enamel following bacterial pH-cycling. Arginine 91-94 C-X-C motif chemokine ligand 8 Homo sapiens 113-116 33711406-4 2021 The experimental and control groups were: 1%, 2%, 4% Arg-NaF, NaF, and no treatment. Arginine 53-56 C-X-C motif chemokine ligand 8 Homo sapiens 57-60 33711406-8 2021 RESULTS: The total carbohydrate content of the biofilm was the lowest for the 2% and 4% Arg-NaF (p < 0.05). Arginine 88-91 C-X-C motif chemokine ligand 8 Homo sapiens 92-95 33711406-9 2021 Except for 2% Arg-NaF, the biofilm proteins for 4% Arg-NaF were significantly higher than the other groups (p < 0.05). Arginine 14-17 C-X-C motif chemokine ligand 8 Homo sapiens 18-21 33711406-9 2021 Except for 2% Arg-NaF, the biofilm proteins for 4% Arg-NaF were significantly higher than the other groups (p < 0.05). Arginine 51-54 C-X-C motif chemokine ligand 8 Homo sapiens 55-58 33711406-10 2021 The amyloids for Arg-NaF groups were significantly lower than the controls (p < 0.05). Arginine 17-20 C-X-C motif chemokine ligand 8 Homo sapiens 21-24 33711406-11 2021 The eDNA for 4% Arg-NaF was significantly higher than the controls (p < 0.05). Arginine 16-19 C-X-C motif chemokine ligand 8 Homo sapiens 20-23 33711406-12 2021 The 2% and 4% Arg-NaF-treated enamel had increased biofilm Pi and F compared to the NaF-treated enamel (p < 0.05). Arginine 14-17 C-X-C motif chemokine ligand 8 Homo sapiens 18-21 33711406-13 2021 The proportion of biofilm EPS matrix to bacteria was significantly reduced in Arg-NaF groups compared to the controls (p < 0.05). Arginine 78-81 C-X-C motif chemokine ligand 8 Homo sapiens 82-85 33711406-14 2021 The dead bacterial proportions of 4% Arg-NaF were significantly higher than the controls (p < 0.05). Arginine 37-40 C-X-C motif chemokine ligand 8 Homo sapiens 41-44 33711406-15 2021 CONCLUSION: Higher concentrations (i.e. 2%/4%) of Arg in 5% NaF varnish have the potential to modulate the biochemical composition of the biofilm growing on the treated enamel. Arginine 50-53 C-X-C motif chemokine ligand 8 Homo sapiens 60-63 33188848-4 2021 Experimental and control groups were: 1% Arg-NaF; 2% Arg-NaF; 4% Arg-NaF; NaF and no treatment. Arginine 41-44 C-X-C motif chemokine ligand 8 Homo sapiens 45-48 33188848-4 2021 Experimental and control groups were: 1% Arg-NaF; 2% Arg-NaF; 4% Arg-NaF; NaF and no treatment. Arginine 53-56 C-X-C motif chemokine ligand 8 Homo sapiens 57-60 33188848-4 2021 Experimental and control groups were: 1% Arg-NaF; 2% Arg-NaF; 4% Arg-NaF; NaF and no treatment. Arginine 53-56 C-X-C motif chemokine ligand 8 Homo sapiens 57-60 33188848-4 2021 Experimental and control groups were: 1% Arg-NaF; 2% Arg-NaF; 4% Arg-NaF; NaF and no treatment. Arginine 53-56 C-X-C motif chemokine ligand 8 Homo sapiens 57-60 33188848-15 2021 The Arg-NaF varnish appears a promising caries-preventive regimen that counters the pathogenic biofilms by Arg and promotes remineralization with fluorides. Arginine 107-110 C-X-C motif chemokine ligand 8 Homo sapiens 8-11 33188848-4 2021 Experimental and control groups were: 1% Arg-NaF; 2% Arg-NaF; 4% Arg-NaF; NaF and no treatment. Arginine 53-56 C-X-C motif chemokine ligand 8 Homo sapiens 57-60 33188848-8 2021 RESULTS: Increasing concentrations of Arg in NaF varnish significantly increased the EFU of incipient caries-like lesions (p < 0.001). Arginine 38-41 C-X-C motif chemokine ligand 8 Homo sapiens 45-48 33188848-9 2021 The PFU for 1% Arg-NaF was significantly higher than 4% Arg-NaF and the control NaF (p < 0.05). Arginine 15-18 C-X-C motif chemokine ligand 8 Homo sapiens 19-22 33188848-9 2021 The PFU for 1% Arg-NaF was significantly higher than 4% Arg-NaF and the control NaF (p < 0.05). Arginine 56-59 C-X-C motif chemokine ligand 8 Homo sapiens 60-63 33188848-9 2021 The PFU for 1% Arg-NaF was significantly higher than 4% Arg-NaF and the control NaF (p < 0.05). Arginine 56-59 C-X-C motif chemokine ligand 8 Homo sapiens 60-63 33188848-10 2021 Post pH-cycling, Ca/P ratio with 1%/2% Arg-NaF was closest to hydroxyapatite (1.67). Arginine 39-42 C-X-C motif chemokine ligand 8 Homo sapiens 43-46 33188848-11 2021 Mineral gain and % remineralization of 1%/2% Arg-NaF was significantly higher than the control NaF varnish (p < 0.05). Arginine 45-48 C-X-C motif chemokine ligand 8 Homo sapiens 49-52 33339152-0 2020 Physicochemical Characteristics of Arginine Enriched NaF Varnish: An In Vitro Study. Arginine 35-43 C-X-C motif chemokine ligand 8 Homo sapiens 53-56 33339152-1 2020 The in vitro study objectives were to investigate the effect of arginine (Arg) incorporation in a 5% sodium fluoride (NaF) varnish on its physical and chemical properties including F/Arg release. Arginine 64-72 C-X-C motif chemokine ligand 8 Homo sapiens 118-121 33339152-1 2020 The in vitro study objectives were to investigate the effect of arginine (Arg) incorporation in a 5% sodium fluoride (NaF) varnish on its physical and chemical properties including F/Arg release. Arginine 74-77 C-X-C motif chemokine ligand 8 Homo sapiens 118-121 33339152-4 2020 Molecular dynamics were simulated to identify post-dynamics total energy for NaF=Arg/Arg>NaF/ArgNaF/ArgNaF/ArgArg concentration denotes the stabilized environment compared to NaF